Evidence map›Paper›PMID 29229863›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Noncanonical thyroid hormone signaling mediates cardiometabolic effects in vivo.

G Sebastian Hönes, Helena Rakov, John Logan, Xiao-Hui Liao, Eugenie Werbenko, Andrea S Pollard, Stine M Præstholm, Majken S Siersbæk, Eddy Rijntjes, Janina Gassen and 18 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 115 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Review
  4. JBMR plus · 2026
    Article
  5. medRxiv : the preprint server for health sciences · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Thyroid Hormone Action by Genomic and Nongenomic Molecular Mechanisms.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 10 institutions in 4 countries.

G Sebastian HönesDepartment of Endocrinology, Diabetes and Metabolism, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Helena RakovDepartment of Endocrinology, Diabetes and Metabolism, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
John LoganMolecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London W12 0NN, United Kingdom.
Xiao-Hui LiaoDepartment of Medicine, The University of Chicago, Chicago, IL 60637.
Eugenie WerbenkoMolecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London W12 0NN, United Kingdom.
Andrea S PollardMolecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London W12 0NN, United Kingdom.
Stine M PræstholmDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense, Denmark.
Majken S SiersbækDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense, Denmark.
Eddy RijntjesCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Experimentelle Endokrinologie, 10117 Berlin, Germany.
Janina GassenDepartment of Endocrinology, Diabetes and Metabolism, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Sören LatteyerDepartment of Endocrinology, Diabetes and Metabolism, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Kathrin EngelsDepartment of Endocrinology, Diabetes and Metabolism, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Karl-Heinz StrucksbergDepartment of Endocrinology, Diabetes and Metabolism, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Petra KleinbongardInstitute for Pathophysiology, West-German Heart and Vascular Center Essen, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Denise ZwanzigerDepartment of Endocrinology, Diabetes and Metabolism, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Jan RozmanGerman Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
Valerie Gailus-DurnerGerman Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
Helmut FuchsGerman Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
Martin Hrabe de AngelisGerman Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
Ludger Klein-HitpassInstitute of Cell Biology (Cancer Research), Faculty of Medicine, University of Duisburg-Essen, 45147 Essen, Germany.
Josef KöhrleCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Experimentelle Endokrinologie, 10117 Berlin, Germany.
David L ArmstrongLaboratory of Neurobiology, National Institute of Environmental Health and Sciences, National Institutes of Health, Research Triangle Park, NC 27709.
Lars GrøntvedDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense, Denmark.
J H Duncan BassettMolecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London W12 0NN, United Kingdom.
Graham R WilliamsMolecular Endocrinology Laboratory, Department of Medicine, Imperial College London, London W12 0NN, United Kingdom.
Samuel RefetoffDepartment of Medicine, The University of Chicago, Chicago, IL 60637.
Dagmar FührerDepartment of Endocrinology, Diabetes and Metabolism, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
Lars C MoellerDepartment of Endocrinology, Diabetes and Metabolism, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany; lars.moeller@uni-due.de.
University of Duisburg-Essen · DEImperial College London · GBUniversity of Southern Denmark · DKCharité - Universitätsmedizin Berlin · DEHelmholtz Zentrum München · DEUniversity of Chicago · USHeinrich Heine University Düsseldorf · DENational Institute of Environmental Health Sciences · USTechnical University of Munich · DEWest German Heart and Vascular Center Essen · DE

Funding

THYROID PHYSIOLOGY STUDIES OF INHERITED DISORDERSR01DK015070 · NIDDK · UNIVERSITY OF CHICAGO · PI ANTONIO C BIANCO, Alexandra Mihaela Dumitrescu · 1986 to 2026
$8.1M
THYROID PHYSIOLOGY STUDIES OF INHERITED DISORDERSR37DK015070 · NIDDK · UNIVERSITY OF CHICAGO · PI REFETOFF, SAMUEL · 1989 to 2015
$5.6M
Thyroid hormone signalingZ01ES102285 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI ARMSTRONG, DAVID · 2007 to 2008
$1.2M
Intramural NIH HHS Z01 ES102285NIDDK NIH HHS R01 DK015070NIDDK NIH HHS R37 DK015070Wellcome TrustWellcome Trust 094134Wellcome Trust 101123
6 · The paper itself

Abstract

Thyroid hormone (TH) and TH receptors (TRs) α and β act by binding to TH response elements (TREs) in regulatory regions of target genes. This nuclear signaling is established as the canonical or type 1 pathway for TH action. Nevertheless, TRs also rapidly activate intracellular second-messenger signaling pathways independently of gene expression (noncanonical or type 3 TR signaling). To test the physiological relevance of noncanonical TR signaling, we generated knockin mice with a mutation in the TR DNA-binding domain that abrogates binding to DNA and leads to complete loss of canonical TH action. We show that several important physiological TH effects are preserved despite the disruption of DNA binding of TRα and TRβ, most notably heart rate, body temperature, blood glucose, and triglyceride concentration, all of which were regulated by noncanonical TR signaling. Additionally, we confirm that TRE-binding-defective TRβ leads to disruption of the hypothalamic-pituitary-thyroid axis with resistance to TH, while mutation of TRα causes a severe delay in skeletal development, thus demonstrating tissue- and TR isoform-specific canonical signaling. These findings provide in vivo evidence that noncanonical TR signaling exerts physiologically important cardiometabolic effects that are distinct from canonical actions. These data challenge the current paradigm that in vivo physiological TH action is mediated exclusively via regulation of gene transcription at the nuclear level.

Indexed as

Signal TransductionAnimalsGene Knock-In TechniquesHypothalamo-Hypophyseal SystemMiceMice, KnockoutMyocardiumPituitary-Adrenal SystemReceptors, Thyroid HormoneThyroid HormonesReceptors, Thyroid HormoneThyroid Hormonescardiometabolic effectsnoncanonical signalingskeletonthyroid hormone actionthyroid hormone receptor

Identifiers

PMID29229863
PMCPMC5748168
OpenAlexW2775358200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.